Biocon’s $1.2bn LBO hits the market

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Biocon’s $1.2bn LBO hits the market

Close up of test tubes-pharma-adobe-2022

The acquisition financing is the second large deal from India this year after Adani-Holcim loan

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article